US pharma giant Johnson & Johnson is set to begin trials of its single-shot Covid-19 vaccines in India soon. The Indian Express has reported that the company has communicated to the Indian drug regulators on starting clinical trials in the country.
Top government sources told The Indian Express that J&J will soon conduct the trials, which could pave the way for its vaccine to be marketed in India.
In India, J&J has tied up with Biological E to expand manufacturing capabilities of its vaccine candidate.
Johnson & Johnson's single dose vaccine will be a great news for India as it is looking to ramp up its vaccine drive amid a second surge in Covid cases.